PA
NEOS

Perceptive Advisors’s Neos Therapeutics, Inc NEOS Stock Holding History

Perceptive Advisors’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-300,000
Closed -$3.06M – 163
2017
Q4 		$3.06M Buy
+300,000
New +$2.88M 0.1% 83
2017
Q1 		– Sell
-1,056
Closed -$6K – 222
2016
Q4 		$6K Sell
1,056
-329,537
-100% -$2.23M ﹤0.01% 170
2016
Q3 		$2.17M Sell
330,593
-296,283
-47% -$2.35M 0.14% 84
2016
Q2 		$4.61M Buy
626,876
+526,876
+527% +$5.03M 0.32% 60
2016
Q1 		$1.08M Sell
100,000
-42,603
-30% -$449K 0.09% 99
2015
Q4 		$2.04M Sell
142,603
-228,463
-62% -$3.45M 0.15% 74
2015
Q3 		$7.8M Buy
+371,066
New +$8.18M 0.62% 40

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors's NEOS Position: Q1 2018 in Review

Perceptive Advisors sold out of Neos Therapeutics, Inc (NEOS) in Q1 2018, closing a stake of 300,000 shares — an estimated $3.06M sold.

Perceptive Advisors first reported a position in NEOS in Q3 2015 and held it in 7 quarters. The position peaked at $7.8M in Q3 2015. 77 funds tracked by Wall St. Rank hold NEOS as of Q1 2018.

  • Perceptive Advisors reported no remaining Neos Therapeutics, Inc position as of Q1 2018 after selling out during the quarter.
  • Perceptive Advisors sold 300,000 Neos Therapeutics, Inc shares in Q1 2018, an estimated $3.06M.
  • Perceptive Advisors first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 7 quarters.
  • Perceptive Advisors's Neos Therapeutics, Inc position peaked at $7.8M in Q3 2015.
  • 77 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2018.

Based on Perceptive Advisors's 13F filing for Q1 2018, filed 15 May 2018.